报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | -15.53% | 0.7% | -11.57% | 146/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
2024-06-30 | -13.92% | -18.07% | -228.3% | 147/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
2024-03-31 | -4.24% | 8.42% | 81.98% | 141/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
2023-12-31 | -23.53% | -0.38% | -50.45% | 139/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
2023-09-30 | -15.64% | -18.66% | -32.65% | 142/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
2023-06-30 | -11.79% | -41.88% | -154.64% | 141/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
2023-03-31 | -4.63% | -40.73% | 80.25% | 138/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
2022-12-31 | -23.44% | -50.45% | -77.85% | 138/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
2022-09-30 | -13.18% | -52.37% | -58.6% | 134/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
2022-06-30 | -8.31% | -50% | -152.58% | 140/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
2022-03-31 | -3.29% | -55.92% | 78.88% | 130/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
2021-12-31 | -15.58% | 47.72% | -80.12% | 136/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
2021-09-30 | -8.65% | 72.11% | -56.14% | 127/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
2021-06-30 | -5.54% | 70.41% | -162.56% | 133/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
2021-03-31 | -2.11% | 70.53% | 92.92% | 120/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
2020-12-31 | -29.8% | 6.58% | 3.93% | 138/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
2020-09-30 | -31.02% | 2% | -65.71% | 116/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
2020-06-30 | -18.72% | 2% | 41.32% | 128/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
2019-12-31 | -31.9% | -1.98% | -345.53% | 129/160 | 2.78% | 汇宇制药 | 31.9% | 行业排名> |
2019-03-31 | -7.16% | 2% | 77.11% | 107/160 | 2.46% | 誉衡药业 | 35.56% | 行业排名> |
2018-12-31 | -31.28% | -357.31% | -357.31% | 132/160 | 7.09% | 奥赛康 | 35% | 行业排名> |
2015-12-31 | -6.84% | -52% | -52% | 100/160 | 11.35% | 奥赛康 | 28.15% | 行业排名> |